Purdue Pharma Appeals Ruling That Invalidated OxyContin Patents

Law360, New York (January 12, 2004, 12:00 AM EST) -- Purdue Pharma filed an appeal Monday of a court ruling that found its patents protecting the painkiller OxyContin were invalid because the company deliberately misled the U.S. Patent Office.

The closely held Connecticut drug maker filed its appeal in the U.S. District Court for the Southern District of New York, stating that it would ask the U.S. Court of Appeals for the Federal Circuit to overturn the District Court's Jan. 5, 2004 ruling.

"By filing our Notice of Appeal promptly, we want to make two things...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.